Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal – Investor's Business Daily
Business News
- Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal Investor’s Business Daily
- Stocks making big premarket moves: WBD, CDTX, AVDL and more CNBC
- Merck agrees $9.2bn deal for flu-prevention biotech Cidara Financial Times
- Merck to Buy Cidara Therapeutics in $9.2 Billion Deal The Wall Street Journal
- This Biotech Stock Soared 100%. Merck Is Buying It. Barron’s
Source: Business News
